USE OF (METH)ACRYLATE COPOLYMERS IN SLOW-RELEASE PHARMACEUTICAL FORMS FOR REDUCING THE INFLUENCE OF ETHANOL ON ACTIVE INGREDIENT RELEASE

摘要

The invention relates to the use of (meth)acrylate copolymers which are insoluble in gastric juice in oral slow-release pharmaceutical forms to form a matrix for the contained active ingredient to reduce the effect of increasing or decreasing the rate of active ingredient release through the influence of ethanol under in vitro conditions.